Exelixis Inc (EXEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EXEL | ASND | ARWR | ||
| Company | Exelixis Inc | Ascendis Pharma ADR | Arrowhead Pharma | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 55.76 | 249.71 | 86.93 | ||
| High | 56.18 | 252.46 | 87.10 | ||
| Low | 52.79 | 243.30 | 84.53 | ||
| Last | 53.03 | 243.91 | 84.65 | ||
| Change | -2.94 | -7.16 | -2.67 | ||
| Percent Change | -5.25% | -2.85% | -3.06% | ||
| Volume | 3,025,500 | 508,800 | 1,657,400 | ||
| 20-Day Average Volume | 2,333,775 | 514,015 | 2,351,910 | ||
| Previous | 55.97 | 251.07 | 87.32 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 55.78 | 259.92 | 81.00 | ||
| 20-Day Raw Stochastic | 5.02% | 1.57% | 57.67% | ||
| 20-Day Relative Strength | 46.54 | 45.42 | 55.89 | ||
| Weighted Alpha | +42.91 | +33.60 | +253.39 | ||
| Today's Opinion | 64% Buy | 64% Buy | 100% Buy | ||
| Yesterday's Opinion | 100% Buy | 88% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.23% since 07/24/26 | -3.92% since 07/24/26 | -1.11% since 07/24/26 | ||
| Low | 52.79 on 07/31/26 | 243.30 on 07/31/26 | 82.77 on 07/28/26 | ||
| High | 56.85 on 07/28/26 | 260.22 on 07/29/26 | 88.16 on 07/30/26 | ||
| 1-Month | |||||
| %Chg | -2.54% since 06/30/26 | -8.55% since 06/30/26 | +3.85% since 06/30/26 | ||
| Low | 52.79 on 07/31/26 | 243.30 on 07/31/26 | 69.88 on 07/15/26 | ||
| High | 57.57 on 07/07/26 | 282.15 on 07/09/26 | 95.49 on 07/22/26 | ||
| 3-Month | |||||
| %Chg | +19.28% since 04/30/26 | +6.33% since 04/30/26 | +15.20% since 04/30/26 | ||
| Low | 43.50 on 05/04/26 | 203.80 on 06/08/26 | 69.30 on 06/02/26 | ||
| High | 57.57 on 07/07/26 | 282.15 on 07/09/26 | 95.49 on 07/22/26 | ||
| 6-Month | |||||
| %Chg | +28.22% since 01/30/26 | +7.88% since 01/30/26 | +22.10% since 01/30/26 | ||
| Low | 39.71 on 03/02/26 | 203.80 on 06/08/26 | 54.02 on 03/13/26 | ||
| High | 57.57 on 07/07/26 | 282.15 on 07/09/26 | 95.49 on 07/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 13,329,355 | 15,214,372 | 11,923,545 | ||
| Shares Outstanding, K | 251,355 | 62,377 | 140,857 | ||
| Annual Sales, $M | 2,320,130,000 | 814,760,000 | 829,450,000 | ||
| Annual Net Income, $M | 782,570,000 | -258,000,000 | -1,630,000 | ||
| Last Qtr Sales, $M | 610,810,000 | 288,620,000 | 73,740,000 | ||
| Last Qtr Income, $M | 210,470,000 | 736,580,000 | -132,730,000 | ||
| 60-Month Beta | 0.42 | 0.37 | 1.26 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.87 on 05/05/26 | 0.32 on 05/07/26 | -0.93 on 05/07/26 | ||
| Latest Earnings Date | 08/05/26 | 08/06/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 18.72 | 0.00 | 0.00 | ||